Announcements Trials
Browse Landscape

Phase

Phase 2 7Phase NA 1Phase 4 1Phase 1 1

Status

Completed 69Recruiting 16Terminated 14Unknown 13Active not recruiting 11Withdrawn 9Not yet recruiting 7Enrolling by invitation 1

Sponsor Class

OTHER 7

Study Type

Interventional 7

Sponsor

Cancer Type

Lymphoid 7Other hematologic neoplasm 1

Conditions

Lymphoma, Mantle-Cell 2Lymphoma 2Waldenstrom Macroglobulinemia 1Lymphoma, Follicular 1Lymphoma, B-Cell 1Leukemia, Lymphocytic, Chronic, B-Cell 1

Interventions

Carboplatin 79Cisplatin 74Bevacizumab 62Radiotherapy 59Drug Therapy 57Capecitabine 57Oxaliplatin 56tislelizumab 54toripalimab 45Paclitaxel 44Gemcitabine 43pembrolizumab 40anlotinib 40Specimen Handling 39sintilimab 37Cyclophosphamide 34130-nm albumin-bound paclitaxel 34Injections 30Pemetrexed 28camrelizumab 26Surgical Procedures, Operative 26Magnetic Resonance Spectroscopy 25lenvatinib 24apatinib 23Docetaxel 23Etoposide 22S 1 (combination) 21Fluorouracil 21Immune Checkpoint Inhibitors 20Biopsy 20

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Phase 2 × Not yet recruiting × Bendamustine Hydrochloride × Clear all
NCT07593482 2026-05-18

FC-BALANCE

Swiss Cancer Institute

Phase 2 Not yet recruiting
92 enrolled
Lymphoid

Lymphoma, B-Cell

NCT07259122 2025-12-02

ZBR in WM

Institute of Hematology & Blood Diseases Hospital, China

Phase 2 Not yet recruiting
43 enrolled
Lymphoid

Waldenstrom Macroglobulinemia

NCT07206264 2025-10-03

ADAPT-MCL

Tianjin Medical University Cancer Institute and Hospital

Phase 2 Not yet recruiting
45 enrolled
Lymphoid

Lymphoma, Lymphoma, Mantle-Cell

NCT07003464 2025-06-04

Phase II Trial of Zanubrutinib, Obinutuzumab, Bendamustine (ZGB) as First-Line Therapy for Chronic Lymphocytic Leukemia: A Single-Center Study

The First Hospital of Jilin University

Phase 2 Not yet recruiting
30 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

NCT06557330 2025-01-06

MRD Guided De-intensification of Bendamustine/Rituximab for Indolent Non-Hodgkin Lymphoma

Fox Chase Cancer Center

Phase 2 Not yet recruiting
24 enrolled
Lymphoid

Lymphoma

NCT06757894 2025-01-03

Efficacy and Safety of Zuberitamab Combined with Bendamustine, Followed by Monotherapy Maintenance, in Treatment-naïve Follicular Lymphoma

Sun Yat-sen University

Phase 2 Not yet recruiting
50 enrolled
Lymphoid

Lymphoma, Follicular

NCT04913103 2021-06-04

CLSGMCLPOLA

Czech Lymphoma Study Group

Phase 2 Not yet recruiting
21 enrolled
Lymphoid

Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡